Clinical Trials
All Clinical Trials - Page 25 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05153564Phase 1Completed
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Semaglutide
- NCT05093634Phase 3Completed
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Setmelanotide
- NCT05153590N/ACompleted
A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
Liraglutide
- NCT07028320Phase 3Completed
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Teriparatide
- NCT05111912Phase 2Completed
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Liraglutide
- NCT04963231Phase 2Completed
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Setmelanotide
- NCT05144984Phase 2Completed
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Semaglutide
- NCT05760222N/AUnknown
Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients
Gonadorelin
- NCT05119179Phase 4Recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
Semaglutide
- NCT05057546Phase 4Active Not Recruiting
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
Gonadorelin
- NCT05132088Phase 3Completed
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Semaglutide
- NCT05086445Phase 1Completed
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Orforglipron
- NCT04243629N/AUnknown
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
Pramlintide
- NCT05110794Phase 1Completed
A Multiple-Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05171751N/ACompleted
Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia
Octreotide
- NCT05071417Phase 3Unknown
Effect Of Semaglutide In Coronary Atheroma Plaque
Semaglutide
- NCT06182891N/ACompleted
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
Dulaglutide
- NCT04958109Phase 1Completed
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Kisspeptin
- NCT05050942Phase 3Active Not Recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Octreotide
- NCT05159752Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Afamelanotide
- NCT05096598Phase 1Completed
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
Petrelintide
- NCT04199728Phase 1/Phase 2Completed
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Liraglutide
- NCT05034783EARLY_Phase 1Unknown
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Exenatide
- NCT05051579Phase 2Completed
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Orforglipron
- NCT05048901Phase 1/Phase 2Recruiting
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Lanreotide
- NCT05051566Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05606471Phase 4Unknown
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
Semaglutide
- NCT05048719Phase 2Completed
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT04897802Phase 4Completed
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Exenatide
- NCT04615871Phase 2Unknown
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
Semaglutide
- NCT05056246Phase 1Completed
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
Maridebart-Cafraglutide
- NCT05046873Phase 1Completed
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
Semaglutide
- NCT04965506Phase 2Completed
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
Dulaglutide
- NCT05024032Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Tirzepatide
- NCT04892199Phase 4Active Not Recruiting
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Semaglutide
- NCT05035082Phase 4Completed
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Semaglutide
- NCT05040087N/AActive Not Recruiting
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
Semaglutide
- NCT04963712EARLY_Phase 1Completed
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
Thymosin-Alpha-1
- NCT03891849N/AWithdrawn
Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock
Octreotide
- NCT05023382N/ACompleted
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Teduglutide
- NCT05137145N/AUnknown
Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation
Linaclotide
- NCT04532879N/AWithdrawn
HygiRelief Procedure and HygiSample Evaluation for Functional Constipation
Linaclotide
- NCT04964466N/AActive Not Recruiting
Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis
Ghrp-6
- NCT04961996Phase 3Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Gonadorelin
- NCT04624672Phase 4Terminated
Treatment of GLP-1 for Diabetic Bariatric Patients
Semaglutide
- NCT05203133N/ACompleted
Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality
Ghrp-6
- NCT05029622Phase 3Completed
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
Gonadorelin
- NCT04971785Phase 2Completed
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Semaglutide
- NCT04862234Phase 4Terminated
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
Dulaglutide
- NCT05046132Phase 4Completed
Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants
Setmelanotide